TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/8/24 12:52 | 2/7/24 | LH | Laboratory Corp of America Holdings | DE | Health | Health | Medical Laboratories | Williams R Sanders | CA | D | M.d | 0 | 0.00 | 0 | 1 | 13 | 8 | D | |||||||||||||||
2/14/23 15:07 | 2/11/23 | LH | Laboratory Corp of America Holdings | DE | Health | Health | Medical Laboratories | Williams R Sanders | CA | D | M.d | 0 | 0.00 | 0 | 1 | 12 | 7 | D | |||||||||||||||
8/22/22 21:03 | 8/22/22 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Williams R Sanders | CA | D | S | -50 | 249.96 | 0 | 0 | -4 | 5 | D | |||||||||||||||
5/23/22 21:19 | 5/23/22 | AMGN | Amgen Inc | DE | Health | BioPrd | Biological Products, (No Diag | Williams R Sanders | CA | D | S | -150 | 250.00 | 0 | -1 | -10 | 6 | D | |||||||||||||||
3/29/22 09:46 | 3/25/22 | LH | Laboratory Corp of America Holdings | DE | Health | Health | Medical Laboratories | Williams R Sanders | CA | D | S | -156 | 272.98 | 0 | -1 | -8 | 6 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |